Explore the latest in opioid use disorders, including recent advances in opioid rehabilitation programs, treatments, and public health interventions.
This cohort study examines the association between mortality and retention within office-based addiction treatment settings in individuals with opioid use disorder who are experiencing homelessness.
This cohort study documents age-related changes in opioid use and analyzes childhood antecedents of opioid use among non-Hispanic White individuals and American Indian individuals.
This Viewpoint discusses policy reforms necessary to advance medical management of opioid use disorder in the wake of retraction by the Biden adminstration of proposed federal Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder.
This Viewpoint discusses federal guidance that would exempt physicians from a standing requirement to apply for a waiver to prescribe buprenorphine for opioid use disorder (OUD) and makes additional recommendations to expand access to medication treatment of OUD, including expanded prescriber training and office-based methadone treatment.
This systematic review assesses the benefits and harms of pharmacologic interventions for breathlessness in adults with advanced cancer.
This case-control cohort study examines whether the use of medications to treat opioid use disorder is associated with decreased risk for alcohol-related falls or injuries and poisonings in persons with opioid use disorder with and without co-occurring alcohol use disorder.
This population-based cohort study assesses the prevalence of opioid use in pregnant women in Ontario, Canada, from 2014 through 2019.
This decision analytical model examines the association of evidence-based practices alone or in combination with reduction of opioid overdose mortality by at least 40% in simulated communities.
This cross-sectional study assesses state drug policies implemented between 2007 and 2018 to ascertain whether they are associated with variations in opioid misuse, opioid use disorder, and drug overdose mortality.
This Viewpoint summarizes a 2021 MMWR report documenting a concerning rise in illicit and synthetic opioid overdose deaths in the US between 2013 and 2019 and proposes strategies to connect clinicians and health systems with public health, public safety, and other community partners to share data, monitor trends, and better respond to the overdose epidemic.
This cross-sectional study examines trends in heroin treatment admission rates in the United States by race, sex, and age from 2000 to 2017.
This cross-sectional analysis uses data from the Centers for Disease Control and Prevention to examine changes in US emergency department visits for mental health, suicide attempts, overdose, and violence outcomes during the COVID-19 pandemic.
This cross-sectional study examines US trends in polysubstance-involved opioid overdose deaths among adolescents and young adults aged 13 to 25 years.
This essay describes the author’s personal experiences witnessing the opioid epidemic and its devastation in Kentucky.
This essay describes how psychiatrists can play an important role in optimizing care for patients who have been prescribed opioids for chronic pain.
This mendelian randomization analysis investigates the potential bidirectional associations between the genetic liability for prescription opioid and other nonopioid pain medications and both major depressive disorder and anxiety and stress-related disorders using genetically based methods
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: